Skip to main content

Want a detailed portfolio tracker?

Immatics N.V (IMTX) P/E (2020 - 2026)

Immatics N.V (IMTX) P/E from Jul 2, 2020 to Jul 21, 2026. The TTM Immatics N.V (IMTX) P/E is -4.71. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Immatics N.V (IMTX)

YearP/EChange
2026-4.71-16.72%
2025-5.65-110.53%
202453.70-661.59%
2023-9.56-172.01%
202213.28-263.32%
2021-8.13+221.01%
2020-2.53N/A

Comparison Immatics N.V (IMTX) P/E with competitors

Immatics N.V (IMTX) P/E is -4.71.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.09%
ENLVEnlivex Ltd0.07-101.59%
FGENFibroGen Inc0.24-105.10%
CHRSCoherus Biosciences Inc0.85-118.02%
FBIOFortress Biotech Inc0.95-120.16%
ORMPOramed Pharmaceuticals Inc1.50-131.92%
AGENAgenus Inc3.01-163.92%
INVAInnoviva Inc3.15-166.98%
VXRTVaxart Inc3.55-175.39%
CRMDCorMedix Inc3.63-177.06%
CVACCureVac N.V.4.45-194.42%
GLPGGalapagos NV4.86-203.19%
SRPTSarepta Therapeutics Inc4.88-203.68%
ABEOAbeona Therapeutics Inc5.39-214.42%
ABUSArbutus Biopharma Corp5.60-218.84%
ZVRAZevra Therapeutics Inc5.89-225.03%
SPROSpero Therapeutics Inc6.23-232.28%
CGENCompugen Ltd6.31-234.09%
RIGLRigel Pharmaceuticals6.87-245.95%
SLXNSilexion Therapeutics Corp7.30-254.95%
OMEROmeros Corporation9.26-296.64%
AUPHAurinia Pharmaceuticals Inc9.58-303.56%
PLXProtalix BioTherapeutics Inc10.89-331.30%
ACADAcadia Pharmaceuticals Inc11.73-349.09%
TBPHTheravance Biopharma Inc12.26-360.42%
ADMAAdma Biologics Inc12.42-363.73%
HRMYHarmony Biosciences Holdings Inc13.82-393.51%
SABSSAB Biotherapeutics Inc14.14-400.22%
NAGENiagen Bioscience Inc14.82-414.71%
INCYIncyte Corp15.82-436.04%
REGNRegeneron Pharmaceuticals Inc15.86-436.76%
PBYIPuma Biotechnology Inc17.32-467.75%
CPRXCatalyst Pharmaceuticals Inc17.44-470.37%
EXELExelixis Inc17.54-472.47%
TGTXTG Therapeutics Inc18.97-502.80%
MDXGMimedx Group Inc20.55-536.49%
XOMAXOMA Royalty Corp22.87-585.82%
ARGXArgen X SE24.30-616.05%
CTMXCytomX Therapeutics Inc24.82-627.16%
XOMAOXOMA Royalty Corp25.34-638.28%
HALOHalozyme Therapeutics Inc25.62-644.21%
XOMAPXOMA Royalty Corp25.67-645.19%
VRTXVertex Pharmaceuticals Inc27.99-694.56%
RPRXRoyalty Pharma plc - Class A28.69-709.28%
SLNOSoleno Therapeutics Inc29.02-716.24%
ASNDAscendis Pharma A/S30.09-738.97%
LGNDLigand Pharmaceuticals Inc - Class B37.91-905.19%
APLSApellis Pharmaceuticals Inc39.02-928.75%
BMRNBiomarin Pharmaceutical Inc42.21-996.51%
KRYSKrystal Biotech Inc45.34-1063.02%
ONCBeiGene Ltd69.54-1576.93%
PHARPharming Group N.V.75.03-1693.43%
TECHBio-Techne Corp101.96-2265.44%
VCELVericel Corp109.92-2434.56%
ALNYAlnylam Pharmaceuticals Inc117.96-2605.40%
GMABGenmab140.29-3079.56%
TLXTelix Pharmaceuticals Ltd162.15-3543.88%
CORTCorcept Therapeutics Inc212.86-4620.77%